Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1975-08-20
1976-07-06
Drezin, Norman A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 3112
Patent
active
039682471
ABSTRACT:
Certain substituted or unsubstituted p-alkanoyl toluenes, e.g., p-alkanoyl toluene, are useful as anti-obesity and anti-diabetic agents.
REFERENCES:
tsatas, Chemical Abstracts 74:42099x (1971).
Ropp et al., Chemical Abstracts 53;6174c (1959).
Pearson et al., Chemical Abstracts 50:4070b (1956).
Landrum et al., Chemical Abstracts 49:15791g (1955).
Landrum et al., Chemical Abstracts 48:13655c (1954).
Ho Robert S.
Houlihan William J.
Nadelson Jeffrey
Drezin Norman A.
Honor Robert S.
Sandoz Inc.
Sharkin Gerald D.
LandOfFree
Substituted or unsubstituted p-alkanoyl toluenes as anti-diabeti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted or unsubstituted p-alkanoyl toluenes as anti-diabeti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted or unsubstituted p-alkanoyl toluenes as anti-diabeti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1533979